Plant ID: NPO17721
Plant Latin Name: Oenothera odorata
Taxonomy Genus: Oenothera
Taxonomy Family: Onagraceae
NCBI TaxonomyDB:
3951
Plant-of-the-World-Online:
n.a.
India
ALOX5; |
Cytochrome P450 Enzymes: |
---|
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0032787; monocarboxylic acid metabolic process | 2.480E-02 | 1.000E+00 | ALOX5 |
BP | GO:0002376; immune system process | GO:0043312; neutrophil degranulation | 2.495E-02 | 1.000E+00 | ALOX5 |
BP | GO:0002376; immune system process | GO:0045321; leukocyte activation | 4.364E-02 | 1.000E+00 | ALOX5 |
BP | GO:0008152; metabolic process | GO:0055114; oxidation-reduction process | 4.649E-02 | 1.000E+00 | ALOX5 |
BP | GO:0009987; cellular process | GO:0032940; secretion by cell | 4.861E-02 | 1.000E+00 | ALOX5 |
CC | GO:0044464; cell part | GO:0005641; nuclear envelope lumen | 4.142E-04 | 1.000E+00 | ALOX5 |
CC | GO:0044464; cell part | GO:0034774; secretory granule lumen | 1.662E-02 | 1.000E+00 | ALOX5 |
MF | GO:0005488; binding | GO:0005506; iron ion binding | 8.283E-03 | 1.000E+00 | ALOX5 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09150 Organismal Systems | 09152 Endocrine system | hsa04913 | Ovarian steroidogenesis | 2.500E-03 | 7.375E-03 | ALOX5 |
09100 Metabolism | 09103 Lipid metabolism | hsa00590 | Arachidonic acid metabolism | 3.100E-03 | 7.375E-03 | ALOX5 |
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 5.600E-03 | 7.375E-03 | ALOX5 |
09160 Human Diseases | 09167 Infectious diseases | hsa05145 | Toxoplasmosis | 5.900E-03 | 7.375E-03 | ALOX5 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 6.195E-02 | 6.195E-02 | ALOX5 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
S00-T88: Injury, poisoning and certain other consequences of external causes | Allergy | T78.4 | ALOX5; |
J00-J99: Diseases of the respiratory system | Rhinitis | J00, J30, J31.0 | ALOX5; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Rheumatoid arthritis | M05-M06 | ALOX5; |
A00-B99: Certain infectious and parasitic diseases | Fungal infections | B35-B49 | ALOX5; |
I00-I99: Diseases of the circulatory system | Thrombosis | I80-I82 | ALOX5; |
J00-J99: Diseases of the respiratory system | Chronic obstructive pulmonary disease | J40-J44, J47 | ALOX5; |
L00-L99: Diseases of the skin and subcutaneous tissue | Psoriasis | L40 | ALOX5; |
L00-L99: Diseases of the skin and subcutaneous tissue | Atopic dermatitis | L00-L99 | ALOX5; |
L00-L99: Diseases of the skin and subcutaneous tissue | Dermatitis | L20-L30 | ALOX5; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Arthritis | M00-M25 | ALOX5; |
J00-J99: Diseases of the respiratory system | Asthma | J45 | ALOX5; |
I00-I99: Diseases of the circulatory system | Atherosclerosis | I70 | ALOX5; |
A00-B99: Certain infectious and parasitic diseases | Lymphatic filariasis | B74 | ALOX5; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Osteoarthritis | M15-M19, M47 | ALOX5; |
E00-E89: Endocrine, nutritional and metabolic diseases | Inflammation | E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, G89 | ALOX5; |
C00-D49: Neoplasms | Inflammatory disease | C11, C44, K75.9, M00-M25 | ALOX5; |
L00-L99: Diseases of the skin and subcutaneous tissue | Pruritus | L29 | ALOX5; |
J00-J99: Diseases of the respiratory system | Respiratory disease | J00-J99 | ALOX5; |